CURRENT CANCER DRUG TARGETS

CURRENT CANCER DRUG TARGETS Journal

publication venue for

CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells. 24:720-732. 2024

International Standard Serial Number (ISSN)

1568-0096

Electronic International Standard Serial Number (EISSN)

1873-5576